BSE: IPCALAB - Ipca Laboratories Limited

六个月盈利: +30.05%
股息率: +0.27%

促销时间表 Ipca Laboratories Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Ipca Laboratories Limited

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic.

更多详情
The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

ISIN INE571A01038
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.3888
Дивиденд ао 4
Сайт https://www.ipca.com
Цена ао 1579.8
每日价格变化: +0.269% (1579.8)
每周价格变化: -8.71% (1735.15)
每月价格变化: +3.23% (1534.55)
3个月内价格变化: -6.93% (1702)
六个月内的价格变化: +30.05% (1218)
每年价格变化: +38.9% (1140.45)
3年内价格变化: -26.56% (2157.05)
5年内价格变化: +40.18% (1130.05)
10年价格变化: 0% (1584.05)
年初以来价格变化: -0.4087% (1590.55)
所有参数

低估

姓名 意义 年级
P/S 3.99 4
P/BV 3.93 4
P/E 55.5 2
EV/EBITDA 19.72 6
全部的: 5.25

效率

姓名 意义 年级
ROA, % 5.55 2
ROE, % 8.99 3
全部的: 2.83

股息

姓名 意义 年级
Div yield, % 0.271 0.68
DSI 0.8571 8.57
全部的: 3.18

责任

姓名 意义 年级
Debt/EBITDA 1.32 8
全部的: 8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 63.93 8
盈利能力 Ebitda, % 40.85 6
盈利能力 EPS, % -10.08 0
全部的: 4.8
更多详情

ETF 分享, % 本年盈利能力, % 股息, %
iShares MSCI India Small-Cap ETF 0.57778 0.4625 0.96163
iShares MSCI Emerging Markets Small-Cap ETF 0.18692 7.67 2.7853
Franklin FTSE India ETF 0.12659 20.52 1.25133
WisdomTree India Earnings Fund 0.07568 5.23 1.65591
Avantis Responsible Emerging Markets Equity ETF 0.07083 17.6 3.1719
Dimensional Emerging Markets Core Equity 2 ETF 0.04731 15.96 3.34087
WisdomTree Emerging Markets SmallCap Dividend Fund 0.03618 1.35 5.00999
Franklin FTSE Asia ex Japan ETF 0.03097 14.43 2.66768
Dimensional Emerging Markets Value ETF 0.02903 17.07 4.19508
SPDR Portfolio Emerging Markets ETF 0.02388 11.59 3.1879
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.02349 12.46 3.59676
Avantis Emerging Markets Equity ETF 0.01625 8.77 3.60513
Dimensional World ex U.S. Core Equity 2 ETF 0.01451 13.06 3.62488
WisdomTree Global ex-U.S. Quality Dividend Growth Fund 0.01118 9.11 2.73928
iShares Core MSCI Total International Stock ETF 0.0103 6.4 3.25258
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.00988 2.43 4.35382

导师 职称 支付 出生年份
Mr. Premchand Godha A.C. A., B. Com., CA Executive Chairman 112.65M 1946 (79 年)
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. CFO, MD & Executive Director 77.54M 1955 (70 年)
Mr. Prashant Premchand Godha Executive Director 46M 1975 (50 年)
Mr. Pawan Kothari Vice President of Operations N/A 1965 (60 年)
Mr. Vishnu Saran Singh Kushwaha Vice President of Technical N/A 1968 (57 年)
Mr. Sunil Ghai President of Marketing N/A 1963 (62 年)
Mr. Sameer S. Tamhane Senior Vice President of Human Resources N/A 1967 (58 年)
Dr. Ashok Kumar President of R&D - Chemicals N/A 1954 (71 年)
Mr. Pranay Premchand Godha CEO, MD & Executive Director 50.98M 1972 (53 年)
Mr. Harish Pandurang Kamath Compliance Officer, Corporate Counsel & Company Secretary 1959 (66 年)

地址: India, Mumbai, 125 Kandivli Industrial Estate - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.ipca.com